bosentan anhydrous has been researched along with Cerebrovascular Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihara, S; Morisaki, H; Muroi, A; Nakai, Y; Shiono, J | 1 |
| Ergul, A; Li, W; Sachidanandam, K | 1 |
| Dumont, AS; Dumont, RJ; Kassell, NF; McNeill, JH; Sutherland, GR; Verma, S | 1 |
| Abassi, Z; Hoffman, A; Ramadan, R; Schwartz, H | 1 |
2 review(s) available for bosentan anhydrous and Cerebrovascular Disorders
| Article | Year |
|---|---|
Nonsurgical treatment of cerebral ischemia associated with ACTA2 cerebral arteriopathy: a case report and literature review.
Topics: Actins; Bosentan; Brain Ischemia; Cerebral Angiography; Cerebral Arterial Diseases; Cerebral Infarction; Cerebrovascular Disorders; Child; Humans; Magnetic Resonance Imaging; Male | 2022 |
[Therapeutic implications of endothelin antagonists for cardiovascular diseases].
Topics: Antihypertensive Agents; Bosentan; Cardiovascular Diseases; Cerebrovascular Disorders; Endothelin Receptor Antagonists; Endothelins; Humans; Sulfonamides | 2004 |
2 other study(ies) available for bosentan anhydrous and Cerebrovascular Disorders
| Article | Year |
|---|---|
Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.
Topics: Animals; Atrasentan; Bosentan; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Vasodilator Agents | 2011 |
Chronic endothelin antagonism restores cerebrovascular function in diabetes.
Topics: Animals; Antihypertensive Agents; Bosentan; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Male; Middle Cerebral Artery; Muscle Development; Potassium Channels; Rats; Rats, Wistar; Receptors, Endothelin; Recovery of Function; Sulfonamides; Vasodilation | 2003 |